Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

NCT01357668 ·Status: ACTIVE_NOT_RECRUITING

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists

NCT00293722 ·Status: COMPLETED

A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database

NCT05421442 ·Status: COMPLETED

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists

NCT00293709 ·Status: COMPLETED

Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis

NCT00558506 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical Practice

NCT01111240 ·Status: COMPLETED

Abatacept Bone Effects in Psoriatic Arthritis With Bone Biomarker

NCT04106804 ·Status: UNKNOWN ·Phase: PHASE4

An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis

NCT00421980 ·Status: COMPLETED ·Phase: PHASE3

Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)?

NCT02164214 ·Status: COMPLETED ·Phase: PHASE3

Etanercept (Enbrel) in Undifferentiated Spondyloarthritis

NCT01289730 ·Status: UNKNOWN ·Phase: PHASE2

Etanercept (Enbrel) in Ankylosing Spondylitis

NCT01289743 ·Status: UNKNOWN ·Phase: PHASE2

Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept

NCT01221636 ·Status: WITHDRAWN ·Phase: PHASE1

The Study of Abatacept in Combination With Etanercept

NCT00162279 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis

NCT00245960 ·Status: COMPLETED ·Phase: PHASE4

Good EULAR Response In Patients With Early Rheumatoid Arthritis

NCT01558089 ·Status: COMPLETED

Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis

NCT04343378 ·Status: COMPLETED

A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis

NCT01298531 ·Status: COMPLETED ·Phase: PHASE4

Observational Trial With Enbrel

NCT00488475 ·Status: COMPLETED

Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries

NCT02632890 ·Status: COMPLETED

A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.

NCT02486302 ·Status: COMPLETED

Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain

NCT00195364 ·Status: COMPLETED

Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.

NCT00393471 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain

NCT00195377 ·Status: COMPLETED

Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis

NCT00913458 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis

NCT00544557 ·Status: COMPLETED